Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonid Zeitlin

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Harefuah|October 21, 2003
[Updates in osteogenesis imperfecta]Leonid Zeitlin, Shlomo Wientroub, Nehemia Blumberg
Journal of Pediatric Orthopedics. Part B|February 14, 2003
Modern approach to children with osteogenesis imperfectaLeonid Zeitlin, François Fassier, Francis H Glorieux
Frontiers in Endocrinology|September 2, 2022
Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapyRafi Brener, Leonid Zeitlin, Yael Lebenthal, et al.
Pediatrics|May 3, 2003
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IVLeonid Zeitlin, Frank Rauch, Horacio Plotkin, et al.
Headache|October 26, 2022
A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extensionMarcy E Yonker, Jennifer McVige, Leonid Zeitlin, et al.
Parkinsonism & Related Disorders|December 28, 2020
Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Robert A Hauser, Leonid Zeitlin, Stanley Fisher, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 4, 2003
Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapyFrank Rauch, Horacio Plotkin, Leonid Zeitlin, et al.
The Journal of Pediatrics|June 1, 2022
Massive Cervical Heterotopic Ossification and Extra-Articular Temporomandibular Joint AnkylosisRuby Haviv, Leonid Zeitlin, Philip J Hashkes, et al.
Journal of Parkinson'S Disease|June 23, 2020
Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome DyskinesiaRobert A Hauser, Leonid Zeitlin, Stanley Fisher, et al.
Therapeutic Advances in Endocrinology and Metabolism|April 2, 2021
Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapyAvivit Brener, Yael Lebenthal, Roxana Cleper, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Harefuah|October 21, 2003
[Updates in osteogenesis imperfecta]Leonid Zeitlin, Shlomo Wientroub, Nehemia Blumberg
Journal of Pediatric Orthopedics. Part B|February 14, 2003
Modern approach to children with osteogenesis imperfectaLeonid Zeitlin, François Fassier, Francis H Glorieux
Frontiers in Endocrinology|September 2, 2022
Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapyRafi Brener, Leonid Zeitlin, Yael Lebenthal, et al.
Pediatrics|May 3, 2003
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IVLeonid Zeitlin, Frank Rauch, Horacio Plotkin, et al.
Headache|October 26, 2022
A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extensionMarcy E Yonker, Jennifer McVige, Leonid Zeitlin, et al.
Parkinsonism & Related Disorders|December 28, 2020
Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Robert A Hauser, Leonid Zeitlin, Stanley Fisher, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 4, 2003
Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapyFrank Rauch, Horacio Plotkin, Leonid Zeitlin, et al.
The Journal of Pediatrics|June 1, 2022
Massive Cervical Heterotopic Ossification and Extra-Articular Temporomandibular Joint AnkylosisRuby Haviv, Leonid Zeitlin, Philip J Hashkes, et al.
Journal of Parkinson'S Disease|June 23, 2020
Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome DyskinesiaRobert A Hauser, Leonid Zeitlin, Stanley Fisher, et al.
Therapeutic Advances in Endocrinology and Metabolism|April 2, 2021
Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapyAvivit Brener, Yael Lebenthal, Roxana Cleper, et al.
Pageof 4